…ching, swelling or pain/tenderness where the injection is given were the most common events (7.2 percent with Praluent versus 5.1 percent with placebo) and resulted in a low discontinuation rate that was comparable to placebo (0.2 percent w...
Fwd: FDA Approved a Potent and Pricey Cholesterol lowering drug today
TEXT-001-HOUSE_OVERSIGHT_025888.txt
p.1
View source release ↗